Ocular Therapeutix (OCUL) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

OCUL Ocular Therapeutix

Watchlist

10.230
-0.230-2.20%

Close Oct 15 16:00 ET

10.230
0.0000.00%

Post 16:55 ET

1.60BMarket Cap-9385P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Ocular Therapeutix Management to Meet With Piper Sandler
TipRanks15:50 ET
Express News | Ocular Therapeutix Inc - Topline Data From Sol-1 Expected in Q4 2025
ReutersOct 15 07:30 ET
Express News | Ocular Therapeutix Inc - Sol-1 Expected to Be Fully Randomized by Year-End 2024
ReutersOct 15 07:30 ET
Ocular Therapeutix Announces Accelerated Timelines for SOL-1 Registrational Trial of AXPAXLI in Wet AMD
GlobeNewswireOct 15 07:30 ET
Express News | Ocular Therapeutix™ Announces Accelerated Timelines for Sol-1 Registrational Trial of Axpaxli™ in Wet AMD
ReutersOct 15 07:30 ET
Ocular Therapeutix (OCUL) Moves 6.1% Higher: Will This Strength Last?
Zacks Oct 14 09:05 ET

Comments

Trytosaveabit

Aug 7 06:11

Update

$Ocular Therapeutix (OCUL.US)$ Ocular Therapeutix Has Received FDA Written Response That Phase 3 Sol-r Trial Is Appropriate For Use As The Company's Second Adequate And Well Controlled Study Of Axpaxli (Axitinib Intravitreal Implant, Also Known As OTX-TKI) For Wet Age-related Macular Degeneration

MARKET-TEST-DUMMY

Jun 15 14:49

This ticker got the gas?

$Ocular Therapeutix (OCUL.US)$

Bigmoney Dreamer

Jun 15 10:21

$Ocular Therapeutix (OCUL.US)$ $Ocular Therapeutix (OCUL.US)$ 👀 price showing action over 200ema worth keeping eye for 6.65$ region breakabove potential multi-bagger